Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2015, Article ID 165867, 20 pages
http://dx.doi.org/10.1155/2015/165867
Research Article

Differential Regulation of Gene Expression of Alveolar Epithelial Cell Markers in Human Lung Adenocarcinoma-Derived A549 Clones

1Department of Molecular Biology, Institute of Health Biosciences, The University of Tokushima Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8504, Japan
2Department of Thoracic and Endocrine Surgery and Oncology, Institute of Health Biosciences, The University of Tokushima Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8504, Japan

Received 8 January 2015; Revised 10 April 2015; Accepted 21 April 2015

Academic Editor: Hannele T. Ruohola-Baker

Copyright © 2015 Hiroshi Kondo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. G. Liou, S. M. Raman, and B. C. Cahill, “Lung transplantation for chronic obstructive pulmonary disease,” Transplant Research and Risk Management, vol. 2013, no. 5, pp. 1–20, 2013. View at Publisher · View at Google Scholar
  2. D. Siniscalco, N. Sullo, S. Maione, F. Rossi, and B. D'Agostino, “Stem cell therapy: the great promise in lung disease,” Therapeutic Advances in Respiratory Disease, vol. 2, no. 3, pp. 173–177, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Tzouvelekis, G. Laurent, and D. Bouros, “Stem cell therapy in chronic obstructive pulmonary disease. Seeking the prometheus effect,” Current Drug Targets, vol. 14, no. 2, pp. 246–252, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Ghaedi, E. A. Calle, J. J. Mendez et al., “Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix,” The Journal of Clinical Investigation, vol. 123, no. 11, pp. 4950–4962, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S. X. L. Huang, M. N. Islam, J. O'Neill et al., “Efficient generation of lung and airway epithelial cells from human pluripotent stem cells,” Nature Biotechnology, vol. 32, no. 1, pp. 84–91, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. M. C. Williams, “Alveolar type I cells: molecular phenotype and development,” Annual Review of Physiology, vol. 65, pp. 669–695, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Dahlin, E. M. Mager, L. Allen et al., “Identification of genes differentially expressed in rat alveolar type I cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 31, no. 3, pp. 309–316, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. S. M. Kreda, M. C. Gynn, D. A. Fenstermacher, R. C. Boucher, and S. E. Gabriel, “Expression and localization of epithelial aquaporins in the adult human lung,” American Journal of Respiratory Cell and Molecular Biology, vol. 24, no. 3, pp. 224–234, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. L. DeMaio, W. Tseng, Z. Balverde et al., “Characterization of mouse alveolar epithelial cell monolayers,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 296, no. 6, pp. L1051–L1058, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. G. R. Newman, L. Campbell, C. von Ruhland, B. Jasani, and M. Gumbleton, “Caveolin and its cellular and subcellular immunolocalisation in lung alveolar epithelium: implications for alveolar epithelial type I cell function,” Cell and Tissue Research, vol. 295, no. 1, pp. 111–120, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Demling, C. Ehrhardt, M. Kasper, M. Laue, L. Knels, and E. P. Rieber, “Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells,” Cell and Tissue Research, vol. 323, no. 3, pp. 475–488, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. R. Rock and B. L. M. Hogan, “Epithelial progenitor cells in lung development, maintenance, repair, and disease,” Annual Review of Cell and Developmental Biology, vol. 27, pp. 493–512, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Fehrenbach, “Alveolar epithelial type II cell: defender of the alveolus revisited,” Respiratory Research, vol. 2, no. 3, pp. 475–488, 2006. View at Publisher · View at Google Scholar
  14. F. Possmayer, “A proposed nomenclature for pulmonary surfactant-associated proteins,” American Review of Respiratory Disease, vol. 138, no. 4, pp. 990–998, 1988. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Kuroki and D. R. Voelker, “Pulmonary surfactant proteins,” The Journal of Biological Chemistry, vol. 269, no. 42, pp. 25943–25946, 1994. View at Google Scholar · View at Scopus
  16. T. Yamaguchi, Y. Hosono, K. Yanagisawa, and T. Takahashi, “NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progression,” Cancer Cell, vol. 23, no. 6, pp. 718–723, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Boggaram, “Thyroid transcription factor-1 (TTF-1/Nkx2.1/TITF1) gene regulation in the lung,” Clinical Science, vol. 116, no. 1, pp. 27–35, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. R. J. Bohinski, R. Di Lauro, and J. A. Whitsett, “The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis,” Molecular and Cellular Biology, vol. 14, no. 9, pp. 5671–5681, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. S. E. Kelly, C. J. Bachurski, M. S. Burhans, and S. W. Glasser, “Transcription of the lung-specific surfactant protein C gene is mediated by thyroid transcription factor 1,” The Journal of Biological Chemistry, vol. 271, no. 12, pp. 6881–6888, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. J. V. Degiulio, C. D. Kaufman, and D. A. Dean, “The SP-C promoter facilitates alveolar type II epithelial cell-specific plasmid nuclear import and gene expression,” Gene Therapy, vol. 17, no. 4, pp. 541–549, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. Evans, L. J. Cabral, R. J. Stephens, and G. Freeman, “Renewal of alveolar epithelium in the rat following exposure to NO2,” The American Journal of Pathology, vol. 70, no. 2, pp. 175–198, 1973. View at Google Scholar · View at Scopus
  22. B. D. Uhal, “Cell cycle kinetics in the alveolar epithelium,” The American Journal of Physiology, vol. 272, no. 6, part 1, pp. L1031–L1045, 1997. View at Google Scholar · View at Scopus
  23. L. B. Ware and M. A. Matthay, “The acute respiratory distress syndrome,” The New England Journal of Medicine, vol. 342, no. 18, pp. 1334–1349, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. G. R. Clegg, C. Tyrrell, S. R. McKechnie, M. F. Beers, D. Harrison, and M. C. McElroy, “Coexpression of RTI40 with alveolar epithelial type II cell proteins in lungs following injury: identification of alveolar intermediate cell types,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 289, no. 3, pp. L382–L390, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. T. J. Desai, D. G. Brownfield, and M. A. Krasnow, “Alveolar progenitor and stem cells in lung development, renewal and cancer,” Nature, vol. 507, no. 7491, pp. 190–194, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. C. E. Barkauskas, M. J. Cronce, C. R. Rackley et al., “Type 2 alveolar cells are stem cells in adult lung,” The Journal of Clinical Investigation, vol. 123, no. 7, pp. 3025–3036, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. D. M. Valenzuela and J. Groffen, “Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene,” Nucleic Acids Research, vol. 14, no. 2, pp. 843–852, 1986. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Krypuy, G. M. Newnham, D. M. Thomas, M. Conron, and A. Dobrovic, “High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer,” BMC Cancer, vol. 6, article 295, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Amann, S. Kalyankrishna, P. P. Massion et al., “Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer,” Cancer Research, vol. 65, no. 1, pp. 226–235, 2005. View at Google Scholar · View at Scopus
  30. M. Lieber, B. Smith, A. Szakal, W. Nelson-Rees, and G. Todaro, “A continuous tumor cell line from a human lung carcinoma with properties of type II alveolar epithelial cells,” International Journal of Cancer, vol. 17, no. 1, pp. 62–70, 1976. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Kolla, L. W. Gonzales, J. Gonzales et al., “Thyroid transcription factor in differentiating type II cells: regulation, isoforms, and target genes,” American Journal of Respiratory Cell and Molecular Biology, vol. 36, no. 2, pp. 213–225, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. I. R. Witherden, E. J. V. Bon, P. Goldstraw, C. Ratcliffe, U. Pastorino, and T. D. Tetley, “Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase,” American Journal of Respiratory Cell and Molecular Biology, vol. 30, no. 4, pp. 500–509, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. M. V. Croce, A. G. Colussi, M. R. Price, and A. Segal-Eiras, “Identification and characterization of different subpopulations in a human lung adenocarcinoma cell line (A549),” Pathology & Oncology Research, vol. 5, no. 3, pp. 197–204, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Rucka, P. Vanhara, I. Koutna et al., “Differential effects of insulin and dexamethasone on pulmonary surfactant-associated genes and proteins in A549 and H441 cells and lung tissue,” International Journal of Molecular Medicine, vol. 32, no. 1, pp. 211–218, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. E. Scott, C.-Y. Tzen, M. M. Witte, S. Blatti, and H. Wang, “Regulation of differentiation, proliferation and cancer suppressor activity,” The International Journal of Developmental Biology, vol. 37, no. 1, pp. 67–74, 1993. View at Google Scholar · View at Scopus
  36. G. L. Semenza, “Targeting HIF-1 for cancer therapy,” Nature Reviews Cancer, vol. 3, no. 10, pp. 721–732, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. Q. Ke and M. Costa, “Hypoxia-inducible factor-1 (HIF-1),” Molecular Pharmacology, vol. 70, no. 5, pp. 1469–1480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. D. T. Dang, F. Chen, L. B. Gardner et al., “Hypoxia-inducible factor-1α promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts,” Cancer Research, vol. 66, no. 3, pp. 1684–1693, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Brognard and P. A. Dennis, “Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants,” Cell Death and Differentiation, vol. 9, no. 9, pp. 893–904, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Niu, Q. Mo, H. Wang, M. Li, J. Cui, and Z. Li, “Invasion inhibition by a MEK inhibitor correlates with the actin-based cytoskeleton in lung cancer A549 cells,” Biochemical and Biophysical Research Communications, vol. 422, no. 1, pp. 80–84, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. T. A. Longmire, L. Ikonomou, F. Hawkins et al., “Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells,” Cell Stem Cell, vol. 10, no. 4, pp. 398–411, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Gotoh, I. Ito, T. Nagasaki et al., “Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells,” Stem Cell Reports, vol. 3, no. 3, pp. 394–403, 2014. View at Publisher · View at Google Scholar
  43. L. W. Gonzales, S. H. Guttentag, K. C. Wade, A. D. Postle, and P. L. Ballard, “Differentiation of human pulmonary type II cells in vitro by glucocorticoid plus cAMP,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 283, no. 5, pp. L940–L951, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. P. L. Ballard, J. W. Lee, X. Fang et al., “Regulated gene expression in cultured type II cells of adult human lung,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 299, no. 1, pp. L36–L50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. C. D. Foster, L. S. Varghese, R. B. Skalina, L. W. Gonzales, and S. H. Guttentag, “In vitro transdifferentiation of human fetal type II cells toward a type I-like cell,” Pediatric Research, vol. 61, no. 4, pp. 404–409, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. K. A. Foster, C. G. Oster, M. M. Mayer, M. L. Avery, and K. L. Audus, “Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism,” Experimental Cell Research, vol. 243, no. 2, pp. 359–366, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. M. E. Winkler, C. Mauritz, S. Groos et al., “Serum-free differentiation of murine embryonic stem cells into alveolar type II epithelial cells,” Cloning and Stem Cells, vol. 10, no. 1, pp. 49–64, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. R. S. Herbst, J. V. Heymach, and S. M. Lippman, “Molecular origins of cancer: lung cancer,” The New England Journal of Medicine, vol. 359, no. 13, pp. 1367–1380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. M. F. Favata, K. Y. Horiuchi, E. J. Manos et al., “Identification of a novel inhibitor of mitogen-activated protein kinase kinase,” The Journal of Biological Chemistry, vol. 273, no. 29, pp. 18623–18632, 1998. View at Publisher · View at Google Scholar · View at Scopus
  50. D. T. Dudley, L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel, “A synthetic inhibitor of the mitogen-activated protein kinase cascade,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 17, pp. 7686–7689, 1995. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Lauand, P. Rezende-Teixeira, B. A. Cortez, E. L. D. O. Niero, and G. M. Machado-Santelli, “Independent of ErbB1 gene copy number, EGF stimulates migration but is not associated with cell proliferation in non-small cell lung cancer,” Cancer Cell International, vol. 13, no. 1, article 38, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. P. W. Cook, P. A. Mattox, W. W. Keeble et al., “A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin,” Molecular and Cellular Biology, vol. 11, no. 5, pp. 2547–2557, 1991. View at Google Scholar · View at Scopus
  53. K. Hashimoto, S. Higashiyama, H. Asada et al., “Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes,” The Journal of Biological Chemistry, vol. 269, no. 31, pp. 20060–20066, 1994. View at Google Scholar · View at Scopus
  54. R. C. Harris, E. Chung, and R. J. Coffey, “EGF receptor ligands,” Experimental Cell Research, vol. 284, no. 1, pp. 2–13, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. E. Kakiashvili, Q. Dan, M. Vandermeer et al., “The epidermal growth factor receptor mediates tumor necrosis factor-α-induced activation of the ERK/GEF-H1/RhoA pathway in tubular epithelium,” The Journal of Biological Chemistry, vol. 286, no. 11, pp. 9268–9279, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. O. Warburg, “On the origin of cancer cells,” Science, vol. 123, no. 3191, pp. 309–314, 1956. View at Publisher · View at Google Scholar · View at Scopus
  57. N. D. Amoêdo, M. F. Rodrigues, P. Pezzuto et al., “Energy metabolism in H460 lung cancer cells: effects of histone deacetylase inhibitors,” PLoS ONE, vol. 6, no. 7, Article ID e22264, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Sugahara, J. S. Rubin, R. J. Mason, E. L. Aronsen, and J. M. Shannon, “Keratinocyte growth factor increases mRNAs for SP-A and SP-B in adult rat alveolar type II cells in culture,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 269, no. 3, part 2, pp. L344–L350, 1995. View at Google Scholar · View at Scopus
  59. N. Chelly, O.-B. Mouhieddine-Gueddiche, A.-M. Barlier-Mur, B. Chailley-Heu, and J. R. Bourbon, “Keratinocyte growth factor enhances maturation of fetal rat lung type II cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 20, no. 3, pp. 423–432, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. Z. Borok, R. L. Lubman, S. I. Danto et al., “Keratinocyte growth factor modulates alveolar epithelial cell phenotype in vitro: expression of aquaporin 5,” American Journal of Respiratory Cell and Molecular Biology, vol. 18, no. 4, pp. 554–561, 1998. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Schmeckebier, C. Mauritz, K. Katsirntaki et al., “Keratinocyte growth factor and dexamethasone plus elevated cAMP levels synergistically support pluripotent stem cell differentiation into alveolar epithelial type II cells,” Tissue Engineering Part A, vol. 19, no. 7-8, pp. 938–951, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. W. Zhou, M. Choi, D. Margineantu et al., “HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition,” The EMBO Journal, vol. 31, no. 9, pp. 2103–2116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Zhao, M. Yee, and M. A. O'Reilly, “Transdifferentiation of alveolar epithelial type II to type I cells is controlled by opposing TGF-β and BMP signaling,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 305, no. 6, pp. L409–L418, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. M. C. Ghosh, V. Gorantla, P. S. Makena et al., “Insulin-like growth factor-I stimulates differentiation of ATII cells to ATI-like cells through activation of Wnt5a,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 305, no. 3, pp. L222–L228, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. N. O. Bianchi, “Y chromosome structural and functional changes in human malignant diseases,” Mutation Research, vol. 682, no. 1, pp. 21–27, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Vijayakumar, D. Garcia, C. H. Hensel et al., “The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in athymic nude mice,” Genes Chromosomes & Cancer, vol. 44, no. 4, pp. 365–372, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Vijayakumar, D. C. Hall, X. T. Reveles et al., “Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization,” Cancer Research, vol. 66, no. 8, pp. 4055–4064, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. L. A. Forsberg, C. Rasi, N. Malmqvist et al., “Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer,” Nature Genetics, vol. 46, no. 6, pp. 624–628, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Kemper, P. L. de Goeje, D. S. Peeper, and R. van Amerongen, “Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapy,” Cancer Research, vol. 74, no. 21, pp. 5937–5941, 2014. View at Publisher · View at Google Scholar
  70. G. J. Riely, J. Marks, and W. Pao, “KRAS mutations in non-small cell lung cancer,” Proceedings of the American Thoracic Society, vol. 6, no. 2, pp. 201–205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. M. D. Siegelin and A. C. Borczuk, “Epidermal growth factor receptor mutations in lung adenocarcinoma,” Laboratory Investigation, vol. 94, no. 2, pp. 129–137, 2014. View at Publisher · View at Google Scholar · View at Scopus